Ultragenyx Pharmaceutical, Inc. (RARE)

19.68 +0.30 (+1.55%) USD  |  NASDAQ  |  Mar 30, 10:59
More

Ultragenyx Pharmaceutical Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Insmed, Inc. Upgrade